Citigroup Inc Adc Therapeutics Sa Transaction History

Citigroup Inc

$217 Billion
Q3 2025

A detailed history of Citigroup Inc transactions in Adc Therapeutics Sa stock. As of the latest transaction made, Citigroup Inc holds 3,444 shares of ADCT stock, worth $13,672. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,444

Previous 26,090 86.8%

Holding current value

$13,672

Previous $69,000 81.16%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 10, 2025	SELL	$2.64 - $4.02 $59,785 - $91,036	-22,646 Reduced 86.8%	3,444 $13,000
Q2 2025 Aug 11, 2025	SELL	$1.1 - $3.67 $34,711 - $115,810	-31,556 Reduced 54.74%	26,090 $69,000
Q1 2025 May 12, 2025	SELL	$1.39 - $2.02 $9,025 - $13,115	-6,493 Reduced 10.12%	57,646 $81,000
Q4 2024 Feb 12, 2025	BUY	$1.89 - $3.48 $9,897 - $18,224	5,237 Added 8.89%	64,139 $127,000
Q3 2024 Nov 12, 2024	BUY	$2.59 - $4.01 $112,610 - $174,350	43,479 Added 281.91%	58,902 $185,000
Q2 2024 Aug 12, 2024	BUY	$2.55 - $5.09 $39,328 - $78,503	15,423 New	15,423 $48,000
Q2 2023 Aug 10, 2023	BUY	$1.9 - $2.66 $3,484 - $4,878	1,834 New	1,834 $3,000
Q4 2022 Feb 09, 2023	BUY	$2.87 - $5.24 $20 - $36	7 Added 22.58%	38 $0
Q3 2022 Nov 10, 2022	SELL	$4.66 - $10.31 $9 - $20	-2 Reduced 6.06%	31 $0
Q1 2022 May 12, 2022	BUY	$13.28 - $20.03 $13 - $20	1 Added 3.13%	33 $0
Q4 2021 Feb 10, 2022	BUY	$19.29 - $31.51 $617 - $1,008	32 New	32 $1,000

Others Institutions Holding ADCT

# of Institutions

Shares Held

67.9M

Call Options Held

68.2K

Put Options Held

75.8K

View Full List

About ADC Therapeutics SA

Ticker ADCT
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,645,296
Market Cap $308M
Description
ADC Therapeutics SA, a commercial-stage biotechnology company, develops antibody drug conjugates (ADC) for patients suffering from hematological malignancies and solid tumors. Its flagship product ZYNLONTA that is in Phase II clinical trial for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma;...

More about ADCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account